Rachel Powell

Statistics

Publications

Citations

354

H-Index

Active since

2015

Affiliations

McLaren Northern Michigan(Current)

Rachel Powell is an author at McLaren Northern Michigan specializing in leukocyte trafficking, inflammatory signaling, and phantom-based dose measurement.

ORCID

Publications per year

2015–2023

Publications

Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P <sub>1</sub> ) and receptor‐5 (S1P <sub>5</sub> ) agonist with autoimmune disease‐modifying activity

Fiona L. Scott, Bryan Clemons, Jennifer L. Brooks et al. · British Journal of Pharmacology · 2016 · 305 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Single‐fraction spine SBRT end‐to‐end testing on TomoTherapy, Vero, TrueBeam, and CyberKnife treatment platforms using a novel anthropomorphic phantom

John J. Gallo, Isaac Kaufman, Rachel Powell et al. · Journal of Applied Clinical Medical Physics · 2015 · 39 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Maximizing Student Outcomes in Schools: Data-Driven Individualized Education Program Goals and Objectives Aligned to the Standards

Rachel Powell, Jennifer Schultz, Rebecca Harvey et al. · Language Speech and Hearing Services in Schools · 2023 · 10 citations · Full text

Education, Curriculum, Speech-language Pathology +17

1–3 of 3